RFP
ACAD icon

Root Financial Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Root Financial Partners’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.43K Sell
289
-43
-13% -$1.03K ﹤0.01% 1855
2025
Q4 		$8.87K Buy
332
+69
+26% +$1.65K ﹤0.01% 1551
2025
Q3 		$5.61K Buy
+263
New +$6.22K ﹤0.01% 1681

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Root Financial Partners's ACAD Position: Q1 2026 in Review

Root Financial Partners reduced its Acadia Pharmaceuticals (ACAD) stake by 13% in Q1 2026, selling an estimated $1.03K and leaving 289 shares worth $6.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Root Financial Partners first reported a position in ACAD in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.87K in Q4 2025. 341 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Root Financial Partners held 289 shares of Acadia Pharmaceuticals worth $6.43K as of Q1 2026.
  • Root Financial Partners sold 43 Acadia Pharmaceuticals shares in Q1 2026, an estimated $1.03K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #1855 holding.
  • Root Financial Partners first reported a position in Acadia Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Root Financial Partners's Acadia Pharmaceuticals position peaked at $8.87K in Q4 2025.
  • 341 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.